Literature DB >> 14572464

Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons.

Paula Dietrich1, Hardy J Rideout, Qiaohong Wang, Leonidas Stefanis.   

Abstract

Proteasomal dysfunction may contribute to neurodegenerative diseases; however, its effects on primary neurons are largely unknown. We have previously reported that pharmacological proteasomal inhibition leads to apoptosis and cytoplasmic ubiquitinated inclusions in primary rat cortical neurons. In cell lines the transcription factor p53 is regulated by the proteasome and in some cases it mediates death following proteasomal inhibition. It is unclear, however, if this is the case in primary neurons. Here we show in proteasome inhibitor-treated cortical neurons an early increase of p53 levels, accompanied by nuclear translocation. At later time points p53 is found sequestered within ubiquitinated inclusions. Compared to controls, p53-deficient mouse neurons show delayed apoptosis, but increased numbers of inclusions, likely secondary to enhanced survival. We conclude that p53 plays a role in cortical neuron apoptosis induced by proteasomal inhibition and, despite the fact that it localizes to inclusions, it is not necessary for their formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572464     DOI: 10.1016/s1044-7431(03)00201-x

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  9 in total

1.  Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of α-Synuclein in Primary Neuronal Cultures and in Vivo.

Authors:  Georgia Dermentzaki; Nikolaos Paschalidis; Panagiotis K Politis; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

2.  Apoptotic actions of p53 require transcriptional activation of PUMA and do not involve a direct mitochondrial/cytoplasmic site of action in postnatal cortical neurons.

Authors:  Takuma Uo; Yoshito Kinoshita; Richard S Morrison
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

3.  Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.

Authors:  Tereza Vogiatzi; Maria Xilouri; Kostas Vekrellis; Leonidas Stefanis
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

4.  LPS-stimulating astrocyte-conditioned medium causes neuronal apoptosis via increasing CDK11(p58) expression in PC12 cells through downregulating AKT pathway.

Authors:  Xiaojuan Liu; Chun Cheng; Bai Shao; Xiaohong Wu; Yuhong Ji; Xiang Lu; Aiguo Shen
Journal:  Cell Mol Neurobiol       Date:  2013-05-24       Impact factor: 5.046

5.  Activation of PERK kinase in neural cells by proteasome inhibitor treatment.

Authors:  Le Zhang; Philip J Ebenezer; Kalavathi Dasuri; Annadora J Bruce-Keller; Sun Ok Fernandez-Kim; Ying Liu; Jeffrey N Keller
Journal:  J Neurochem       Date:  2009-10-24       Impact factor: 5.372

Review 6.  The Proteasome Inhibition Model of Parkinson's Disease.

Authors:  Eduard Bentea; Lise Verbruggen; Ann Massie
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

7.  Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.

Authors:  Maria Xilouri; Tereza Vogiatzi; Kostas Vekrellis; David Park; Leonidas Stefanis
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

8.  Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.

Authors:  Georgia Dermentzaki; Evangelia Dimitriou; Maria Xilouri; Helen Michelakakis; Leonidas Stefanis
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Blood Plasma of Patients with Parkinson's Disease Increases Alpha-Synuclein Aggregation and Neurotoxicity.

Authors:  Peng Wang; Xin Li; Xuran Li; Weiwei Yang; Shun Yu
Journal:  Parkinsons Dis       Date:  2016-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.